Legend Biotech Corp. (LEGN)
17.87
-0.34
(-1.87%)
USD |
NASDAQ |
Mar 19, 16:00
17.92
+0.05
(+0.28%)
After-Hours: 20:00
Legend Biotech EPS Diluted (Quarterly) : -0.1673 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.098 |
| Corcept Therapeutics, Inc. | 0.1994 |
| Amicus Therapeutics, Inc. | 0.0054 |
| Incyte Corp. | 1.462 |
| Ultragenyx Pharmaceutical, Inc. | -1.291 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.95M |
| Revenue (Quarterly) | 307.71M |
| Total Expenses (Quarterly) | 338.66M |
| Enterprise Value | 2.763B |
| Gross Profit Margin (Quarterly) | 55.80% |
| Profit Margin (Quarterly) | -10.06% |
| Earnings Yield | -9.04% |
| Normalized Earnings Yield | -9.017 |